If you have a high tolerance for risk, then it could be worth adding some exposure to to your investment portfolio. Especially when analysts are tipping the three in this article to deliver outsized returns for investors over the next 12 months. Here's what you need to know about these buy-rated small cap ASX shares: AVITA Medical could be a small cap to buy according to analysts at Morgans.
It is a regenerative medicine company with a focus on wound care management and skin restoration with its RECELL technology. The broker notes that the US FDA has just its RECELL Go product. It is an autologous cell harvesting device, harnessing the regenerative properties of a patient's own skin to treat burn wounds and full-thickness skin defects.
The broker sees this a very big milestone for the company. Morgans said: AVH has received FDA approval for its automated product, RECELL Go, for use in burns and full thickness skin defects. This approval marks a significant milestone for the company, with management expecting this device to increase adoption of the technology amongst clinicians.
We have made no changes to our forecasts and recommendation. Its analysts have an add rating and $5.60 price target on the company's shares.
This implies that its shares could more than double in value. ( ) Another small cap ASX share that Morgans rates highly is Camplify. It is a peer-to-peer recreational vehicle (RV) rental operator.
Morgans likes the company due to its market leadership position and.